Detalhe da pesquisa
1.
Gating Harmonization Guidelines for Intracellular Cytokine Staining Validated in Second International Multiconsortia Proficiency Panel Conducted by Cancer Immunotherapy Consortium (CIC/CRI).
Cytometry A
; 99(1): 107-116, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090656
2.
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Nature
; 519(7543): 366-9, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762141
3.
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).
Cancer Immunol Immunother
; 66(12): 1589-1595, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28825123
4.
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy.
Cancer Immunol Immunother
; 65(2): 205-11, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26759007
5.
Performance and Stability of New Class of Fetal Bovine Sera (FBS) and Its Lyophilized Form in ELISpot and FluoroSpot Assays: Applications for Monitoring the Immune Response in Vaccine, and Cell and Gene Immunotherapy in Clinical Trials.
Methods Mol Biol
; 2768: 305-316, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502401
6.
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
Cancer Immunol Immunother
; 62(6): 983-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23591978
7.
Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.
J Exp Med
; 196(1): 135-40, 2002 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12093878
8.
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.
Clin Cancer Res
; 25(1): 358-368, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425092
9.
A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis.
J Immunol Methods
; 459: 90-93, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29859231
10.
CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response.
Oncoimmunology
; 7(12): e1502904, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30524899
11.
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
Clin Cancer Res
; 24(15): 3611-3631, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29703821
12.
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Cancer Res
; 78(1): 256-264, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29093005
13.
A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers.
ACS Biomater Sci Eng
; 3(12): 3128-3132, 2017 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30740520
14.
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
Clin Cancer Res
; 23(8): 1898-1909, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28411277
15.
Immunotherapy for malignant glioma.
Surg Neurol Int
; 6(Suppl 1): S68-77, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25722935
16.
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.
Cancer Immunol Res
; 3(4): 320-5, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25387895
17.
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development.
AIDS Res Hum Retroviruses
; 19(2): 133-44, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12639249
18.
Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy.
Oncoimmunology
; 3(7): e944054, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25610727
19.
EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.
Clin Cancer Res
; 20(4): 972-84, 2014 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24352643
20.
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody.
Cancer Immunol Res
; 1(3): 163, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24570975